The two most researched healing peptides do overlapping but distinct jobs. BPC-157 is a targeted repair tool with a strong gut protection profile. TB-500 is a systemic cell migration signal that works across tissues at once. Here is how they actually compare, and how to pick one, or stack both. Educational reference only, not medical advice.
| BPC-157 | TB-500 | |
|---|---|---|
| Class | Synthetic 15 amino acid fragment of body protection compound from gastric juice. | Synthetic 17 amino acid fragment of Thymosin Beta-4, a natural regeneration peptide. |
| Primary action | Localized tissue repair, angiogenesis, and gastrointestinal protection at the site of use. | Systemic cell migration, actin regulation, and cardiovascular / vascular repair throughout the body. |
| Best known for | Tendon and ligament healing, gut lining repair, ulcer protection, and NSAID damage recovery. | Muscle recovery, chronic soft tissue injuries, cardiac tissue support, and full-body inflammation reduction. |
| Onset | Users often report noticeable relief in 5 to 10 days for acute tendon or gut issues. | Slower ramp: benefits typically compound over 2 to 4 weeks of loading. |
| Typical dose | 200 to 500 mcg once or twice daily, subcutaneous near the injury when possible. | 2 to 2.5 mg twice weekly during a 4 to 6 week loading phase, then a weekly maintenance dose. |
| Route | Subcutaneous is standard; oral BPC-157 arginate salt is used specifically for gut work. | Subcutaneous or intramuscular; site does not need to be near the injury because it works systemically. |
| Half life | Short (roughly minutes in plasma) but stable in tissue with sustained local effect. | Longer systemic action; twice weekly dosing covers coverage for most protocols. |
| Side effects | Generally well tolerated; mild injection site reactions and occasional lightheadedness. | Generally well tolerated; temporary fatigue or head pressure during loading is the common complaint. |
| Best fit | Localized injuries, gut and GI complaints, joint or tendon flare ups that need targeted repair. | Chronic, diffuse, or hard to reach injuries and full-body recovery when a single site is hard to identify. |
BPC-157 upregulates growth hormone receptors at the injury site, drives angiogenesis (new blood vessels feeding damaged tissue), and modulates nitric oxide to keep blood flowing to healing zones. Its signature trick is protecting and rebuilding the gastrointestinal lining, which is why it is the go to for NSAID damage, IBS flares, and leaky gut complaints alongside tendon and ligament work.
TB-500 is the active fragment of Thymosin Beta-4, a regeneration signal your body already makes. It binds free actin so cells can migrate to injured tissue, upregulates VEGF for new vasculature, and reduces inflammatory cytokines. Because it circulates systemically, it does not need to be injected near the injury and it hits several sites at once, including cardiac and vascular tissue.
The combination is common in healing protocols because their mechanisms are complementary, not redundant. BPC-157 rebuilds and protects locally, especially at the gut and connective tissue level, while TB-500 helps cells migrate into damaged zones system wide. A typical stack: BPC-157 250 to 500 mcg twice daily plus TB-500 2 to 2.5 mg twice weekly during the loading phase, dropped back to weekly TB-500 once symptoms improve.
Educational content only. Not medical advice. Consult a licensed clinician before starting any peptide protocol.